Remove 2023 Remove Diagnostic Imaging Remove Nuclear Medicine
article thumbnail

Bipartisan bill aims to boost Medicare patients’ access to diagnostic imaging agents

Radiology Business

The Facilitating Innovative Nuclear Diagnostics Act of 2023 would eliminate barriers to nuclear medicine, supporters charged.

article thumbnail

IMV: PET procedure volumes continue strong growth trend

AuntMinnie

in 2024 compared with 2023, according to the newly published IMV 2025 PET Market Summary Report. Follow IMV Medical Information on LinkedIn for more diagnostic imaging updates. Davin Korstjens is the Director of Market Intelligence at IMV Medical Information Division, part of Science and Medicine Group.

PET Scan 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives. His area of expertise is neuroradiology, with a special emphasis on diagnostic imaging of the head, neck, brain, and spine. Elliot Fishman, MD.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.

article thumbnail

Helen Nadel, MD, FRCPC, on Imperatives for Nuclear Medicine and Molecular Imaging

Diagnostic Imaging

Nadel was announced as president of SNMMI for the 2023-2024 term at the 2023 SNMMI annual meeting taking place in Chicago.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.